原发性醛固酮增多症微创治疗2例并文献复习
Two Cases and Literature Review of Minimally Invasive Treatment of Primary Aldosteronism
DOI: 10.12677/acm.2025.15113217, PDF,   
作者: 邢娟娟:同济大学附属东方医院胶州医院内分泌科,山东 青岛;杨利波:青岛大学附属泰安市中心医院内分泌科,山东 青岛;杨丽丽:青岛大学附属医院门诊部,山东 青岛;吕文山:青岛大学附属医院内分泌与代谢性疾病科,山东 青岛;闫洪领, 王 瑶*:青岛市市立医院内分泌科,山东 青岛
关键词: 原发性醛固酮增多症微创治疗腹腔镜切除术肾上腺动脉栓塞术Primary Aldosteronism Minimally Invasive Treatment Laparoscopic Resection Adrenal Artery Embolization
摘要: 原发性醛固酮增多症(PA)是由肾上腺皮质过度分泌醛固酮所致的一种临床综合征,其主要病因包括单侧肾上腺腺瘤、双侧肾上腺增生及单侧肾上腺增生等,而双侧肾上腺腺瘤较为少见。在临床诊疗中,常需借助肾上腺静脉采血(AVS)以明确醛固酮分泌的优势侧。本文报道2例确诊醛固酮瘤的PA患者,病例1肾上腺增强CT提示双侧肾上腺可疑结节,行AVS明确优势侧接受肾上腺动脉栓塞术治疗;病例2肾上腺CT提示左侧肾上腺腺瘤(可能),接受腹腔镜手术治疗。结合相关文献,对比分析腹腔镜手术与血管介入在PA治疗中的疗效差异,以期为临床医师选择个体化治疗方案提供参考。
Abstract: Primary aldosteronism (PA) is a clinical syndrome caused by excessive aldosterone secretion from the adrenal cortex. Its main etiologies include unilateral adrenal adenoma, bilateral adrenal hyperplasia, and unilateral adrenal hyperplasia, while bilateral adrenal adenoma is relatively rare. In clinical diagnosis and treatment, adrenal venous sampling (AVS) is often used to identify the dominant side of aldosterone secretion. This article reports 2 PA patients diagnosed with an aldosterone-producing adenoma. In Case 1, enhanced adrenal CT showed suspicious bilateral adrenal nodules, and AVS was performed to confirm the dominant side before adrenal artery embolization was given. In Case 2, adrenal CT indicated a possible left adrenal adenoma, and the patient underwent laparoscopic surgery. Combined with relevant literature, this article compares and analyzes the efficacy differences between laparoscopic surgery and vascular interventional therapy in the treatment of PA, aiming to provide references for clinicians in selecting individualized treatment plans.
文章引用:邢娟娟, 杨利波, 杨丽丽, 吕文山, 闫洪领, 王瑶. 原发性醛固酮增多症微创治疗2例并文献复习[J]. 临床医学进展, 2025, 15(11): 1252-1261. https://doi.org/10.12677/acm.2025.15113217

参考文献

[1] 中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2024版) [J]. 中华内分泌代谢杂志, 2025, 41(1): 12-24.
[2] Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., et al. (2003) Primary Aldosteronism and Hypertensive Disease. Hypertension, 42, 161-165. [Google Scholar] [CrossRef] [PubMed]
[3] Calhoun, D.A. (2007) Is There an Unrecognized Epidemic of Primary Aldosteronism? (Pro). Hypertension, 50, 447-453. [Google Scholar] [CrossRef] [PubMed]
[4] Loh, K. (2000) Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore. Journal of Clinical Endocrinology & Metabolism, 85, 2854-2859. [Google Scholar] [CrossRef] [PubMed]
[5] Xu, Z. et al. (2020) Primary Aldosteronism in Patients in China with Recently Detected Hypertension. Journal of the American College of Cardiology, 75, 1913-1922.
[6] 中国内分泌代谢病专科联盟. 原发性醛固酮增多症诊治行业标准[J]. 中华内分泌代谢杂志, 2022, 38(7): 555-557.
[7] Reincke, M., Bancos, I., Mulatero, P., Scholl, U.I., Stowasser, M. and Williams, T.A. (2021) Diagnosis and Treatment of Primary Aldosteronism. The Lancet Diabetes & Endocrinology, 9, 876-892. [Google Scholar] [CrossRef] [PubMed]
[8] Funder, J.W., Carey, R.M., Mantero, F., Murad, M.H., Reincke, M., Shibata, H., et al. (2016) The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 101, 1889-1916. [Google Scholar] [CrossRef] [PubMed]
[9] Rossi, G.P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., et al. (2006) A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients. Journal of the American College of Cardiology, 48, 2293-2300. [Google Scholar] [CrossRef] [PubMed]
[10] DeCarlo, K.E. and Agrawal, N. (2017) Double Hit! A Unique Case of Resistant Hypertension. BMJ Case Reports, 2017, bcr-2017-221530. [Google Scholar] [CrossRef] [PubMed]
[11] Reincke, M., Fischer, E., Gerum, S., Merkle, K., Schulz, S., Pallauf, A., et al. (2012) Observational Study Mortality in Treated Primary Aldosteronism. Hypertension, 60, 618-624. [Google Scholar] [CrossRef] [PubMed]
[12] Monticone, S., Sconfienza, E., D’Ascenzo, F., Buffolo, F., Satoh, F., Sechi, L.A., et al. (2020) Renal Damage in Primary Aldosteronism: A Systematic Review and Meta-Analysis. Journal of Hypertension, 38, 3-12. [Google Scholar] [CrossRef] [PubMed]
[13] Briet, M. and Schiffrin, E.L. (2010) Aldosterone: Effects on the Kidney and Cardiovascular System. Nature Reviews Nephrology, 6, 261-273. [Google Scholar] [CrossRef] [PubMed]
[14] Savard, S., Amar, L., Plouin, P. and Steichen, O. (2013) Cardiovascular Complications Associated with Primary Aldosteronism: A Controlled Cross-Sectional Study. Hypertension, 62, 331-336. [Google Scholar] [CrossRef] [PubMed]
[15] Milliez, P., Girerd, X., Plouin, P., Blacher, J., Safar, M.E. and Mourad, J. (2005) Evidence for an Increased Rate of Cardiovascular Events in Patients with Primary Aldosteronism. Journal of the American College of Cardiology, 45, 1243-1248. [Google Scholar] [CrossRef] [PubMed]
[16] Catena, C., Colussi, G., Lapenna, R., Nadalini, E., Chiuch, A., Gianfagna, P., et al. (2007) Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients with Primary Aldosteronism. Hypertension, 50, 911-918. [Google Scholar] [CrossRef] [PubMed]
[17] Monticone, S., D’Ascenzo, F., Moretti, C., Williams, T.A., Veglio, F., Gaita, F., et al. (2018) Cardiovascular Events and Target Organ Damage in Primary Aldosteronism Compared with Essential Hypertension: A Systematic Review and Meta-Analysis. The Lancet Diabetes & Endocrinology, 6, 41-50. [Google Scholar] [CrossRef] [PubMed]
[18] Adler, G.K., et al. (2025) Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 110, 2453-2495.
[19] Inoue, H., Nakajo, M., Miyazono, N., Nishida, H., Ueno, K. and Hokotate, H. (1997) Transcatheter Arterial Ablation of Aldosteronomas with High-Concentration Ethanol: Preliminary and Long-Term Results. American Journal of Roentgenology, 168, 1241-1245. [Google Scholar] [CrossRef] [PubMed]
[20] Hokotate, H., Inoue, H., Baba, Y., Tsuchimochi, S. and Nakajo, M. (2003) Aldosteronomas: Experience with Superselective Adrenal Arterial Embolization in 33 Cases. Radiology, 227, 401-406. [Google Scholar] [CrossRef] [PubMed]
[21] 董徽, 蒋雄京, 关婷, 等. 经皮超选择性肾上腺动脉栓塞治疗原发性醛固酮增多症[J]. 中华高血压杂志, 2013, 21(6): 536-541.
[22] 陈硕, 周锐飞, 董一飞, 等. 江西省首例经皮超选择性肾上腺动脉栓塞报道[J]. 江西医药, 2018, 53(4): 319-321.
[23] Steichen, O., Zinzindohoué, F., Plouin, P. and Amar, L. (2012) Outcomes of Adrenalectomy in Patients with Unilateral Primary Aldosteronism: A Review. Hormone and Metabolic Research, 44, 221-227. [Google Scholar] [CrossRef] [PubMed]
[24] Rossi, G.P., Cesari, M., Cuspidi, C., Maiolino, G., Cicala, M.V., Bisogni, V., et al. (2013) Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy with Treatment of Primary Aldosteronism. Hypertension, 62, 62-69. [Google Scholar] [CrossRef] [PubMed]
[25] Lumachi, F., Ermani, M., Basso, S.M.M., Armanini, D., Iacobone, M. and Favia, G. (2005) Long-Term Results of Adrenalectomy in Patients with Aldosterone-Producing Adenomas: Multivariate Analysis of Factors Affecting Unresolved Hypertension and Review of the Literature. The American Surgeon™, 71, 864-869. [Google Scholar] [CrossRef